Inhaled budesonide for early treatment of COVID-19.

Choi, Jae Chol; Kim, Won-Young

Choi, Jae Chol; Kim, Won-Young.

Choi JC; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Dongjak-gu, Seoul 06973, South Korea.
Kim WY; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Dongjak-gu, Seoul 06973, South Korea. Electronic address: wykim81@cau.ac.kr.

Lancet Respir Med ; 9(7): e60, 2021 07.

Article in English | MEDLINE | ID: covidwho-1225446

Subject(s)

Budesonide; COVID-19; Administration, Inhalation; Bronchodilator Agents/therapeutic use; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Budesonide / COVID-19 Limits: Humans Language: English Journal: Lancet Respir Med Year: 2021 Document Type: Article Affiliation country: S2213-2600(21)00217-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google